DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial

Iqbal Iqbal; S Verheye; A Abizaid; J Ormiston; T Vries; L Morrison; S Toyloy; P Fitzgerald; S Windecker; PWJC (Patrick) Serruys

doi:10.4244/eijy15m10_04

DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial

Iqbal Iqbal, S Verheye, A Abizaid, J Ormiston, T Vries, L Morrison, S Toyloy, P Fitzgerald, S Windecker, PWJC (Patrick) Serruys

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	e1336-e1342
Journal	EuroIntervention
Volume	12
Issue number	11
DOIs	https://doi.org/10.4244/eijy15m10_04
Publication status	Published - 2016

Access to Document

10.4244/eijy15m10_04

Cite this

Iqbal, I., Verheye, S., Abizaid, A., Ormiston, J., Vries, T., Morrison, L., Toyloy, S., Fitzgerald, P., Windecker, S., & Serruys, PWJC. (2016). DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial. EuroIntervention, 12(11), e1336-e1342. https://doi.org/10.4244/eijy15m10_04

Iqbal, Iqbal ; Verheye, S ; Abizaid, A ; Ormiston, J ; Vries, T ; Morrison, L ; Toyloy, S ; Fitzgerald, P ; Windecker, S ; Serruys, PWJC (Patrick). / DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial. In: EuroIntervention. 2016 ; Vol. 12, No. 11. pp. e1336-e1342.

@article{9684912a78b94e12a84aea9376884c6c,

title = "DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial",

author = "Iqbal Iqbal and S Verheye and A Abizaid and J Ormiston and T Vries and L Morrison and S Toyloy and P Fitzgerald and S Windecker and Serruys, {PWJC (Patrick)}",

year = "2016",

doi = "10.4244/eijy15m10_04",

language = "Undefined/Unknown",

volume = "12",

pages = "e1336--e1342",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "EuroPCR",

number = "11",

}

Iqbal, I, Verheye, S, Abizaid, A, Ormiston, J, Vries, T, Morrison, L, Toyloy, S, Fitzgerald, P, Windecker, S & Serruys, PWJC 2016, 'DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial', EuroIntervention, vol. 12, no. 11, pp. e1336-e1342. https://doi.org/10.4244/eijy15m10_04

DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial. / Iqbal, Iqbal; Verheye, S; Abizaid, A; Ormiston, J; Vries, T; Morrison, L; Toyloy, S; Fitzgerald, P; Windecker, S; Serruys, PWJC (Patrick).

In: EuroIntervention, Vol. 12, No. 11, 2016, p. e1336-e1342.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial

AU - Iqbal, Iqbal

AU - Verheye, S

AU - Abizaid, A

AU - Ormiston, J

AU - Vries, T

AU - Morrison, L

AU - Toyloy, S

AU - Fitzgerald, P

AU - Windecker, S

AU - Serruys, PWJC (Patrick)

PY - 2016

Y1 - 2016

U2 - 10.4244/eijy15m10_04

DO - 10.4244/eijy15m10_04

M3 - Article

VL - 12

SP - e1336-e1342

JO - EuroIntervention

JF - EuroIntervention

SN - 1774-024X

IS - 11

ER -